Literature DB >> 26450608

Probiotic attributes, antioxidant, anti-inflammatory and neuromodulatory effects of Enterococcus faecium CFR 3003: in vitro and in vivo evidence.

G Divyashri1,2, G Krishna3, S G Prapulla2.   

Abstract

Accumulating evidence suggests that probiotic bacteria play a vital role in modulating various aspects integral to the health and well-being of humans. In the present study, probiotic attributes and the antioxidant, anti-inflammatory and neuromodulatory potential of Enterococcus faecium CFR 3003 were investigated by employing suitable model systems. E. faecium exhibited robust resistance to gastrointestinal stress conditions as it could withstand acid stress at pH 1.5, 2 and 3. The bacterium also survived at a bile salt concentration of 0.45 %, and better tolerance was observed towards pepsin and trypsin. E. faecium produced lactic acid as a major metabolic product, followed by butyric acid. Lyophilized cell-free supernatant (LCS) of E. faecium exhibited significant antioxidant capacity evaluated against 1,1-diphenyl-2-picryl-hydrazyl, ascorbate auto-oxidation, oxygen radical absorbance and reducing power. Interestingly, E. faecium, Lactobacillus rhamnosus GG MTCC 1408 and LCS showed a significant anti-inflammatory effect by negatively modulating TNF-α production and upregulating IL-10 levels in LPS-stimulated macrophage cell lines. In an in vivo mice model, the propensity of probiotic supplements to modulate endogenous oxidative markers and redox status in brain regions was assessed. Young mice provided with oral supplements (daily for 28 days) of E. faecium and L. rhamnosus exhibited diminished oxidative markers in the brain and enhanced activities of antioxidant enzymes with a concomitant increase in γ-aminobutyric acid and dopamine levels. Collectively, our findings clearly suggest the propensity of these bacteria to protect against tissue damage mediated through free radicals and inflammatory cytokines. Although the underlying molecular mechanisms need further studies, it is tempting to speculate that probiotics confer a neuroprotective advantage in vivo against oxidative damage-mediated neurodegenerative conditions.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26450608     DOI: 10.1099/jmm.0.000184

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

Review 1.  The Microbiota, Immunoregulation, and Mental Health: Implications for Public Health.

Authors:  Christopher A Lowry; David G Smith; Philip H Siebler; Dominic Schmidt; Christopher E Stamper; James E Hassell; Paula S Yamashita; James H Fox; Stefan O Reber; Lisa A Brenner; Andrew J Hoisington; Teodor T Postolache; Kerry A Kinney; Dante Marciani; Mark Hernandez; Sian M J Hemmings; Stefanie Malan-Muller; Kenneth P Wright; Rob Knight; Charles L Raison; Graham A W Rook
Journal:  Curr Environ Health Rep       Date:  2016-09

Review 2.  Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis.

Authors:  Hadi Atabati; Esmaeil Yazdanpanah; Hamed Mortazavi; Saeed Gharibian Bajestani; Amir Raoofi; Seyed-Alireza Esmaeili; Azad Khaledi; Ehsan Saburi; Jalil Tavakol Afshari; Thozhukat Sathyapalan; Abbas Shapouri Moghaddam; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Cross-species examination of single- and multi-strain probiotic treatment effects on neuropsychiatric outcomes.

Authors:  Jamie M Joseph; Catrin Law
Journal:  Neurosci Biobehav Rev       Date:  2018-11-22       Impact factor: 8.989

4.  The Potential of Lactobacillus casei and Entercoccus faecium Combination as a Preventive Probiotic Against Entamoeba.

Authors:  Nitya Sarjapuram; Niharika Mekala; Meetali Singh; Utpal Tatu
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

5.  Probiotic modulation of the microbiota-gut-brain axis and behaviour in zebrafish.

Authors:  Luca Borrelli; Serena Aceto; Claudio Agnisola; Sofia De Paolo; Ludovico Dipineto; Roman M Stilling; Timothy G Dinan; John F Cryan; Lucia F Menna; Alessandro Fioretti
Journal:  Sci Rep       Date:  2016-07-15       Impact factor: 4.379

Review 6.  The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.

Authors:  Ya-Hui Ding; Lin-Yan Qian; Jie Pang; Jing-Yang Lin; Qiang Xu; Li-Hong Wang; Dong-Sheng Huang; Hai Zou
Journal:  Oncotarget       Date:  2017-06-02

Review 7.  The microbiome of the built environment and mental health.

Authors:  Andrew J Hoisington; Lisa A Brenner; Kerry A Kinney; Teodor T Postolache; Christopher A Lowry
Journal:  Microbiome       Date:  2015-12-17       Impact factor: 14.650

Review 8.  Therapies for Prevention and Treatment of Alzheimer's Disease.

Authors:  J Mendiola-Precoma; L C Berumen; K Padilla; G Garcia-Alcocer
Journal:  Biomed Res Int       Date:  2016-07-28       Impact factor: 3.411

9.  Effects of the Oral Ingestion of Probiotics on Brain Damage in a Transient Model of Focal Cerebral Ischemia in Mice.

Authors:  Kobra Akhoundzadeh; Abedin Vakili; Mahdi Shadnoush; Jafar Sadeghzadeh
Journal:  Iran J Med Sci       Date:  2018-01

10.  The Anti-Stress Effect of Mentha arvensis in Immobilized Rats.

Authors:  Weishun Tian; Md Rashedunnabi Akanda; Anowarul Islam; Hae-Dong Yang; Sang-Cheon Lee; Jeong-Ho Lee; Sang-Ki Kim; Yu-Jin Choi; So-Yeon Im; Byung-Yong Park
Journal:  Int J Mol Sci       Date:  2018-01-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.